154 related articles for article (PubMed ID: 20950071)
1. Health-state utility values in breast cancer.
Peasgood T; Ward SE; Brazier J
Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):553-66. PubMed ID: 20950071
[TBL] [Abstract][Full Text] [Related]
2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.
Melnikow J; Birch S; Slee C; McCarthy TJ; Helms LJ; Kuppermann M
Med Care; 2008 Sep; 46(9):946-53. PubMed ID: 18725849
[TBL] [Abstract][Full Text] [Related]
4. Patient-based utilities for bipolar disorder-related health states.
Revicki DA; Hanlon J; Martin S; Gyulai L; Nassir Ghaemi S; Lynch F; Mannix S; Kleinman L
J Affect Disord; 2005 Aug; 87(2-3):203-10. PubMed ID: 16005983
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
McNaughton-Collins M; Walker-Corkery E; Barry MJ
J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
[TBL] [Abstract][Full Text] [Related]
6. Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review.
Paracha N; Thuresson PO; Moreno SG; MacGilchrist KS
Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):549-559. PubMed ID: 27574879
[TBL] [Abstract][Full Text] [Related]
7. Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service.
Marchetti M; Caruggi M; Colombo G
Clin Ther; 2004 Sep; 26(9):1546-61. PubMed ID: 15531017
[TBL] [Abstract][Full Text] [Related]
8. The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review.
Harrison MJ; Davies LM; Bansback NJ; Ingram M; Anis AH; Symmons DP
J Rheumatol; 2008 Apr; 35(4):592-602. PubMed ID: 18278841
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
[TBL] [Abstract][Full Text] [Related]
10. Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index.
Dan AA; Kallman JB; Srivastava R; Younoszai Z; Kim A; Younossi ZM
Liver Transpl; 2008 Mar; 14(3):321-6. PubMed ID: 18306356
[TBL] [Abstract][Full Text] [Related]
11. Preferences for health outcomes and cost-utility analysis.
Torrance GW
Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
[TBL] [Abstract][Full Text] [Related]
12. Utility Values for Adults with Unipolar Depression: Systematic Review and Meta-Analysis.
Mohiuddin S; Payne K
Med Decis Making; 2014 Jul; 34(5):666-85. PubMed ID: 24695961
[TBL] [Abstract][Full Text] [Related]
13. Utility and work productivity data for economic evaluation of breast cancer therapies in the Netherlands and Sweden.
Frederix GW; Quadri N; Hövels AM; van de Wetering FT; Tamminga H; Schellens JH; Lloyd AJ
Clin Ther; 2013 Apr; 35(4):e1-7. PubMed ID: 23541706
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review and Meta-analysis of Childhood Health Utilities.
Kwon J; Kim SW; Ungar WJ; Tsiplova K; Madan J; Petrou S
Med Decis Making; 2018 Apr; 38(3):277-305. PubMed ID: 28990449
[TBL] [Abstract][Full Text] [Related]
15. Health state utilities for metastatic breast cancer in Taiwan.
Chou TC; Chiang SC; Ko Y
Breast; 2020 Jun; 51():57-64. PubMed ID: 32213442
[TBL] [Abstract][Full Text] [Related]
16. Mapping utilities from cancer-specific health-related quality of life instruments: a review of the literature.
McTaggart-Cowan H; Teckle P; Peacock S
Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):753-65. PubMed ID: 24219051
[TBL] [Abstract][Full Text] [Related]
17. A review and meta-analysis of utility values for lung cancer.
Sturza J
Med Decis Making; 2010; 30(6):685-93. PubMed ID: 20448248
[TBL] [Abstract][Full Text] [Related]
18. A review and meta-analysis of prostate cancer utilities.
Bremner KE; Chong CA; Tomlinson G; Alibhai SM; Krahn MD
Med Decis Making; 2007; 27(3):288-98. PubMed ID: 17502448
[TBL] [Abstract][Full Text] [Related]
19. A Meta-Regression Analysis of Utility Weights for Breast Cancer: The Power of Patients' Experience.
Gong JR; Han J; Lee D; Bae S
Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33333997
[TBL] [Abstract][Full Text] [Related]
20. A Review and Meta-analysis of Colorectal Cancer Utilities.
Djalalov S; Rabeneck L; Tomlinson G; Bremner KE; Hilsden R; Hoch JS
Med Decis Making; 2014 Aug; 34(6):809-18. PubMed ID: 24903121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
